Abstract | INTRODUCTION: An 8-week trial of amlodipine/valsartan/ hydrochlorothiazide (Aml/Val/ HCTZ) for moderate or severe hypertension demonstrated more-pronounced blood pressure (BP)-lowering effects compared with dual-component therapies. To elucidate the effects of time and baseline BP on the observed responses, exploratory analyses were performed. METHODS: Patients aged 18-85 years with mean sitting systolic BP (MSSBP) 145 to <200 mmHg and mean sitting diastolic BP (MSDBP) 100 to <120 mmHg were randomized to Aml 10 mg/Val 320 mg/ HCTZ 25 mg; Val 320 mg/ HCTZ 25 mg; Aml 10 mg/Val 320 mg; or Aml 10 mg/ HCTZ 25 mg. During the first 2 weeks, regimens were force-titrated in two stages. RESULTS: All least-square mean reductions in MSSBP and MSDBP (baseline to Week 3 and end of study) were significantly greater with triple therapy than with each dual therapy in the overall population and the severe systolic subgroup (baseline MSSBP > or =180 mmHg; except vs. Aml 10 mg/Val 320 mg at Week 3). At Week 3, more patients on triple therapy achieved MSSBP reductions of > or =-60, > or =-50, > or =-40, > or =-30, and > or =-20 mmHg (2.5%, 9.7%, 23.2%, 46.9% and 74.5%, respectively) than those on dual therapy (1.1%-2%, 5.6%-5.9%, 14.5%-16.7%, 33.5%-39.1%, and 58.8%-65.5%, respectively); this was also true at study endpoint. End-of-study MSSBP reductions were greater in triple- therapy recipients who had higher (vs. lower) baseline MSSBPs. LSM reductions ranged from -27.2 mmHg for baseline MSSBP 145 to <150 mmHg, to > or =49.6 mmHg for baseline MSSBP > or =180 mmHg. All treatments were well tolerated regardless of baseline MSSBP. CONCLUSION: Aml 10 mg/Val 320 mg/ HCTZ 25 mg triple therapy is highly effective in reducing BP compared with dual components early in therapy, and systolic BP-lowering effects were proportionate to hypertension severity.
|
Authors | David A Calhoun, Nora A Crikelair, Joseph Yen, Robert D Glazer |
Journal | Advances in therapy
(Adv Ther)
Vol. 26
Issue 11
Pg. 1012-23
(Nov 2009)
ISSN: 1865-8652 [Electronic] United States |
PMID | 20024680
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Drug Combinations
- Tetrazoles
- Hydrochlorothiazide
- Amlodipine
- Valsartan
- Valine
|
Topics |
- Adolescent
- Adult
- Amlodipine
(administration & dosage, adverse effects, therapeutic use)
- Antihypertensive Agents
(administration & dosage, adverse effects, therapeutic use)
- Blood Pressure
(drug effects)
- Double-Blind Method
- Drug Combinations
- Female
- Humans
- Hydrochlorothiazide
(administration & dosage, adverse effects, therapeutic use)
- Hypertension
(drug therapy)
- Male
- Tetrazoles
(administration & dosage, adverse effects, therapeutic use)
- Valine
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Valsartan
|